Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland

Familial hypercholesterolemia (FH) is the most common monogenic autosomal dominant disorder. FH results in an increased cardiovascular mortality rate. However, cardiovascular risk control factors enable the avoidance of approximately 80% of strokes and cardiovascular diseases. Therefore, early detec...

Full description

Bibliographic Details
Main Authors: Matylda Hennig, Agnieszka Brandt-Varma, Anna Wołoszyn-Durkiewicz, Joanna Bautembach-Minkowska, Marta Buraczewska, Dominik Świętoń, Agnieszka Mickiewicz, Andrzej Rynkiewicz, Marcin Gruchała, Janusz Limon, Bartosz Wasąg, Magdalena Chmara, Mieczysław Walczak, Małgorzata Myśliwiec
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/10/11/270
_version_ 1797548863126503424
author Matylda Hennig
Agnieszka Brandt-Varma
Anna Wołoszyn-Durkiewicz
Joanna Bautembach-Minkowska
Marta Buraczewska
Dominik Świętoń
Agnieszka Mickiewicz
Andrzej Rynkiewicz
Marcin Gruchała
Janusz Limon
Bartosz Wasąg
Magdalena Chmara
Mieczysław Walczak
Małgorzata Myśliwiec
author_facet Matylda Hennig
Agnieszka Brandt-Varma
Anna Wołoszyn-Durkiewicz
Joanna Bautembach-Minkowska
Marta Buraczewska
Dominik Świętoń
Agnieszka Mickiewicz
Andrzej Rynkiewicz
Marcin Gruchała
Janusz Limon
Bartosz Wasąg
Magdalena Chmara
Mieczysław Walczak
Małgorzata Myśliwiec
author_sort Matylda Hennig
collection DOAJ
description Familial hypercholesterolemia (FH) is the most common monogenic autosomal dominant disorder. FH results in an increased cardiovascular mortality rate. However, cardiovascular risk control factors enable the avoidance of approximately 80% of strokes and cardiovascular diseases. Therefore, early detection and implementation of lipid-lowering treatment is essential. In the present study, 57 pediatric patients aged 9.57 ± 3.26 years with FH were enrolled in the study. Researchers checked the lipid profile and performed the ultrasound imaging including intima-media thickness (IMT) measurement and echo (e)-tracking in the study group. Patients were treated with a low-cholesterol diet solely or along with pharmacological treatment with statins. Subsequently, patients were monitored for 12 months. The positive results of dietary treatment were observed in 40 patients. The efficacy of 12 months of nutritional therapy along with pharmacological treatment was reported in 27 patients. We observed a significant decrease in the carotid beta index stiffness and an insignificant decrease in the IMT in the group of patients treated with statins. The obtained data show that statin therapy in children with FH allow for the reduction of the degree of atherosclerotic vessel changes.
first_indexed 2024-03-10T15:05:51Z
format Article
id doaj.art-2bae1ecc8632449497d2c25e24b8223b
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T15:05:51Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-2bae1ecc8632449497d2c25e24b8223b2023-11-20T19:44:00ZengMDPI AGLife2075-17292020-11-01101127010.3390/life10110270Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in PolandMatylda Hennig0Agnieszka Brandt-Varma1Anna Wołoszyn-Durkiewicz2Joanna Bautembach-Minkowska3Marta Buraczewska4Dominik Świętoń5Agnieszka Mickiewicz6Andrzej Rynkiewicz7Marcin Gruchała8Janusz Limon9Bartosz Wasąg10Magdalena Chmara11Mieczysław Walczak12Małgorzata Myśliwiec13The Department of Paediatrics, Diabetology and Endocrinology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandSurrey and Sussex Healthcare NHS Trust, Canada Avenue, Redhill RH15RH, UKThe Department of Paediatrics, Diabetology and Endocrinology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandThe Department of Paediatrics, Diabetology and Endocrinology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandThe Department of Neonatology, Specialized Hospital in Wejherowo, 84-200 Wejherowo, PolandThe Department of Radiology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandThe Department of Cardiology I, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandThe Department of Cardiology and Cardiosurgery, Ist Cardiology Clinic, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, PolandThe Department of Cardiology I, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandThe Department of Biology and Genetics, Faculty of Medicine, Medical University of Gdańsk, 80-210 Gdansk, PolandThe Department of Biology and Genetics, Faculty of Medicine, Medical University of Gdańsk, 80-210 Gdansk, PolandThe Department of Biology and Genetics, Faculty of Medicine, Medical University of Gdańsk, 80-210 Gdansk, PolandThe Department of Paediatrics, Endocrinology, Diabetology, Metabolic Diseases and Developmental Cardiology, Faculty of Medicine, Pomeranian Medical University, 70-204 Szczecin, PolandThe Department of Paediatrics, Diabetology and Endocrinology, Faculty of Medicine, Medical University of Gdansk, 80-210 Gdansk, PolandFamilial hypercholesterolemia (FH) is the most common monogenic autosomal dominant disorder. FH results in an increased cardiovascular mortality rate. However, cardiovascular risk control factors enable the avoidance of approximately 80% of strokes and cardiovascular diseases. Therefore, early detection and implementation of lipid-lowering treatment is essential. In the present study, 57 pediatric patients aged 9.57 ± 3.26 years with FH were enrolled in the study. Researchers checked the lipid profile and performed the ultrasound imaging including intima-media thickness (IMT) measurement and echo (e)-tracking in the study group. Patients were treated with a low-cholesterol diet solely or along with pharmacological treatment with statins. Subsequently, patients were monitored for 12 months. The positive results of dietary treatment were observed in 40 patients. The efficacy of 12 months of nutritional therapy along with pharmacological treatment was reported in 27 patients. We observed a significant decrease in the carotid beta index stiffness and an insignificant decrease in the IMT in the group of patients treated with statins. The obtained data show that statin therapy in children with FH allow for the reduction of the degree of atherosclerotic vessel changes.https://www.mdpi.com/2075-1729/10/11/270hypercholesterolemiacarotid intima-media thicknesscardiovascular diseaseatherosclerosis
spellingShingle Matylda Hennig
Agnieszka Brandt-Varma
Anna Wołoszyn-Durkiewicz
Joanna Bautembach-Minkowska
Marta Buraczewska
Dominik Świętoń
Agnieszka Mickiewicz
Andrzej Rynkiewicz
Marcin Gruchała
Janusz Limon
Bartosz Wasąg
Magdalena Chmara
Mieczysław Walczak
Małgorzata Myśliwiec
Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland
Life
hypercholesterolemia
carotid intima-media thickness
cardiovascular disease
atherosclerosis
title Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland
title_full Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland
title_fullStr Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland
title_full_unstemmed Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland
title_short Monitoring the Effects of Hypolipidemic Treatment in Children with Familial Hypercholesterolemia in Poland
title_sort monitoring the effects of hypolipidemic treatment in children with familial hypercholesterolemia in poland
topic hypercholesterolemia
carotid intima-media thickness
cardiovascular disease
atherosclerosis
url https://www.mdpi.com/2075-1729/10/11/270
work_keys_str_mv AT matyldahennig monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT agnieszkabrandtvarma monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT annawołoszyndurkiewicz monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT joannabautembachminkowska monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT martaburaczewska monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT dominikswieton monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT agnieszkamickiewicz monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT andrzejrynkiewicz monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT marcingruchała monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT januszlimon monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT bartoszwasag monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT magdalenachmara monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT mieczysławwalczak monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland
AT małgorzatamysliwiec monitoringtheeffectsofhypolipidemictreatmentinchildrenwithfamilialhypercholesterolemiainpoland